Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (62)

Advertisement

Research Article Free access | 10.1172/JCI115309

Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters.

H A Lehr, C Hübner, B Finckh, S Angermüller, D Nolte, U Beisiegel, A Kohlschütter, and K Messmer

Department of Experimental Surgery, University of Heidelberg, Germany.

Find articles by Lehr, H. in: JCI | PubMed | Google Scholar

Department of Experimental Surgery, University of Heidelberg, Germany.

Find articles by Hübner, C. in: JCI | PubMed | Google Scholar

Department of Experimental Surgery, University of Heidelberg, Germany.

Find articles by Finckh, B. in: JCI | PubMed | Google Scholar

Department of Experimental Surgery, University of Heidelberg, Germany.

Find articles by Angermüller, S. in: JCI | PubMed | Google Scholar

Department of Experimental Surgery, University of Heidelberg, Germany.

Find articles by Nolte, D. in: JCI | PubMed | Google Scholar

Department of Experimental Surgery, University of Heidelberg, Germany.

Find articles by Beisiegel, U. in: JCI | PubMed | Google Scholar

Department of Experimental Surgery, University of Heidelberg, Germany.

Find articles by Kohlschütter, A. in: JCI | PubMed | Google Scholar

Department of Experimental Surgery, University of Heidelberg, Germany.

Find articles by Messmer, K. in: JCI | PubMed | Google Scholar

Published July 1, 1991 - More info

Published in Volume 88, Issue 1 on July 1, 1991
J Clin Invest. 1991;88(1):9–14. https://doi.org/10.1172/JCI115309.
© 1991 The American Society for Clinical Investigation
Published July 1, 1991 - Version history
View PDF
Abstract

In vitro studies indicate that oxidatively modified low density lipoprotein (oxLDL) promotes leukocyte adhesion to the vascular endothelium, a constant feature of early atherogenesis. Using intravital fluorescence microscopy in the dorsal skinfold chamber model in awake Syrian golden hamsters, we studied whether (a) oxLDL elicits leukocyte/endothelium interaction in vivo, and whether (b) leukotrienes play a mediator role in this event. Leukocyte/endothelium interaction was assessed in the time course after intravenous injection of native human LDL (4 mg/kg body wt) and of oxLDL (7.5 microM Cu++, 6 h, 37 degrees C) into control hamsters and into hamsters, pretreated with the selective leukotriene biosynthesis inhibitor MK-886 (20 mumol/kg, i.v.). While no effect was seen after injection of native LDL, oxLDL elicited an immediate induction of leukocyte adhesion to the endothelium of arterioles and postcapillary venules. Total and differential leukocyte counts suggest that all leukocyte subsets were likewise affected by oxLDL with no specific preference for monocytes. Stimulation of leukocyte adhesion was entirely prevented in inhibitor-treated animals, suggesting the important mediator role of leukotrienes in oxLDL-induced leukocyte/endothelium interaction.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 9
page 9
icon of scanned page 10
page 10
icon of scanned page 11
page 11
icon of scanned page 12
page 12
icon of scanned page 13
page 13
icon of scanned page 14
page 14
Version history
  • Version 1 (July 1, 1991): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (62)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts